{
  "term": "Daxas",
  "role": "concept",
  "parent_concepts": [
    "AntiInflammatory"
  ],
  "layer": 6,
  "domain": "PhysicalWorld",
  "definition": "a selective phosphodiesterase-4 inhibitor used as an oral anti-inflammatory medication for the treatment of severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations; known generically as roflumilast",
  "aliases": [
    "daxas",
    "roflumilast",
    "daliresp",
    "pde4 inhibitor"
  ],
  "wordnet": {
    "synsets": [
      "daxas.n.01"
    ],
    "canonical_synset": "daxas.n.01",
    "lemmas": [
      "daxas",
      "roflumilast",
      "daliresp",
      "pde4 inhibitor"
    ],
    "pos": "noun"
  },
  "relationships": {
    "related": [],
    "antonyms": [],
    "has_part": [],
    "part_of": []
  },
  "safety_tags": {
    "risk_level": "low",
    "impacts": [],
    "treaty_relevant": false,
    "harness_relevant": false
  },
  "training_hints": {
    "positive_examples": [],
    "negative_examples": [],
    "disambiguation": "",
    "seed_terms": [
      "daxas",
      "roflumilast",
      "daliresp",
      "pde4 inhibitor"
    ]
  },
  "is_category_lens": true,
  "child_count": 0
}